1 Fine J, Eady R, Bauer E, et al. The classification of inherited epidermolysis bullosa (EB): report of the third international consensus meeting on diagnosis and classification of EB. J Am Acad Dermatol 2008; 58: 931-950. 2 Gardella R, Zoppi N, Zambruno G, et al. Different phenotypes in recessive dystrophic epidermolysis bullosa patients sharing the same mutation in compound heterozygosity with two novel mutations in the type VII collagen gene. Br J Dermatol 2002; 147: 450-457. 3 Kern J, Kohlhase J, Bruckner-Tuderman L, et al. Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa. J Invest Dermatol 2006; 126: 1006-1012. 4 Varki R, Sadowski S, Uitto J, et al. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 2007; 44: 181-192. 5 Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the national EB registry experience, 1986-2006. J Am Acad Dermatol 2008; 60: 203-211. 6 Shimizu H, McGrath J, Christiano A, et al. Molecular basis of recessive dystrophic epidermolysis bullosa: genotype/phenotype correlation in a case of moderate clinical severity. J Invest Dermatol 1996; 106: 119-124. ª 2014 The International Society of Dermatology Genotype-phenotype correlation in recessive dystrophic epidermolysis bullosa: when missense doesnt make sense. J Invest Dermatol 2005; 124: 863-866. 8 Titeux M, Pendaries V, Tonasso L, et al. A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 2008; 29: 267-276. 9 Kern J, Gr€uninger G, Imsak R, et al. Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort. Br J Dermatol 2009; 161: 1089-1097. 10 Bodemer C, Tchen SI, Ghomrasseni S, et al. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation. J Invest Dermatol 2003; 121: 273-279. 11 Garza-G! omez J. Level of type VII collagen at the basement membrane does not always correlate with clinical severity in a cohort of 13 Mexican patients with recessive dystrophic epidermolysis bullosa. Annual meeting of the society of investigative dermatology, Montreal, Canada. J Investig Dermatol 2009; S87. 12 Hovnanian A, Duquesnoy P, Amselem S, et al. Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype. J Clin Invest 1991; 88: 1716-1721. 13 Colombi M, Gardella R, Zoppi N, et al. Exclusion of stromelysin-1, stromelysin-2, interstitial collagenase and fibronectin genes as the mutant loci in a family with recessive epidermolysis bullosa dystrophica and a form of cerebellar ataxia. Hum Genet 1992; 89: 503-507. 14 Bauer E, Eisen A. Recessive dystrophic epidermolysis bullosa. Evidence for increased collagenase as a genetic characteristic in cell culture. J Exp Med 1978; 148: 1378-1387. 15 Stricklin G, Welgus H, Bauer E. Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures. J Clin Invest 1982; 69: 1373-1383. 16 Vincenti MP, White LA, Schroen DJ, et al. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996; 6: 391-411. 17 Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997; 89: 1260-1270. 18 Seltzer J, Eisen A, Bauer E, et al. Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem 1989; 264: 3822-3826. 19 Ala-aho R, K€ ah€ari V. Collagenases in cancer. Biochimie 2005; 87: 273-286. International Journal of Dermatology 2014 nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58: 5321- 5325. 21 Ghilardi G, Biondi M, Mangoni J, et al. Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001; 7: 2344-2346. 22 Ye S, Dhillon S, Turner S, et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 2001; 61: 1296-1298. 23 I.N.E.G.I Census, 2010. Instituto Nacional de Estad!ıstica Geograf!ıa e Inform!atica(http://www.INEGI.gob.mx). 24 Cerda-Flores RM, Kshatriya GK, Barton SA, et al. Genetic structure of the populations migrating from San Luis Potosi and Zacatecas to Nuevo Le! on in Mexico. Hum Biol 1991; 63: 309-327. 25 Cerda-Flores RM, Villalobos-Torres MC, Barrera-Salda~ HA, et al. Genetic admixture in three Mexican Mestizo populations based on D1S80 and HLA-DQA1 loci. Am J Hum Biol 2002; 14: 257-263. likelihood estimates of admixture in Northeastern Mexico using 13 short tandem repeat loci. Am J Hum Biol 2002; 14: 429-439. 27 Moss C, Wong A, Davies P. The Birmingham epidermolysis bullosa severity score: development and validation. Br J Dermatol 2009; 160: 1057-1065. 28 Rits IA. Declaration of Helsinki. Recommendations Guidins doctors in clinical research. World Med J 1964; 11: 281. 29 Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, 2000: 365-386. 30 Kearse M, Moir R, Wilson A, et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012; 28: 1647-1649. 31 Salas-Alan!ıs JC, McGrath JA. 2470insG, represents the na commonest mutation in Mexican patients with dystrophic bullous epidermolysis. A study of 21 families. Gac Med Mex 2006; 142: 29-34. International Journal of Dermatology 2014 ª 2014 The International Society of Dermatology